You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Swedish Patent and Market Court of Appeal has announced its judgment in a case concerning a subcontracting agreement, related to a public procurement of clinical physiology services. The Patent and Market Court of Appeal dismissed the Swedish Competition Authority's request for fines and acquAlready a subscriber Login You have…
Idogen announces that the European Patent Office (EPO) has issued a Notice of Intention to Grant, which means that the patent office intends to grant Idogen’s patent application, covering the company’s tolerogenic vaccine technology. A related patent application received a Notice of AllowanceAlready a subscriber Login You have read all…
Targovax announces that the US Patent and Trademark Office has granted US Patent no 9,757,439, which protects Targovax' mutant-RAS specific neoantigen vaccines, TG01 and TG02, for the treatment of cancer in combination with anti-metabolite chemotherapy. "We are delighted that this US patent has bAlready a subscriber Login You have read…
Modus Therapeutics has submitted a patent application claiming the use of sevuparin, its lead asset, for the treatment of kidney disease. The patent application is based on novel preclinical work that was undertaken in an established kidney disease animal model during an academic collaboration prAlready a subscriber Login You have…
